As of March 31, 2017

Trade Name Takara Holdings Inc.
Head Office 20 Naginataboko-cho, Shijo-dori Karasuma
Higashi-iru, Shimogyo-ku, Kyoto
600-8688, Japan
Telephone +81-75-241-5130
Established September 6, 1925
Issued Capital ¥13,226 million
Company Representative Toshio Kakimoto, President
Number of Employees

101  (Non-consolidated)

Number of Group Employees


Board of Directors
(As of June 29, 2017)

Chairman Hisashi Ohmiya
President Toshio Kakimoto
Vice President Mutsumi Kimura

Managing Director Minoru Washino

Director Koichi Nakao
Director Kazuyoshi Ito
Director Kenji Murata
External Director Yukiko Yabu

External Director Toshihiko Yoshida

Audit & Supervisory Board Members
*Standing Audit & Supervisory Board Members
(As of June 29, 2017)

Yuzo Watanabe*
Toshihito Yamanaka*
Shinji Ueda*
Tomoyuki Mieda*
Kumiko Kitai

Takara Group Business Chronicles

1842 Commencing sake brewing business.

Shochu and mirin businesses are launched.


Continuous distilled shochu is launched.

1925 Takara Shuzo Co., Ltd. is established.
1933 Sho-Chiku-Bai Shuzo Co., Ltd. is established and begins manufacture and sale of Sho-Chiku-Bai brand sake.
1949 Takara Shuzo Co., Ltd. is listed on the Tokyo Stock Exchange.
1957 Entering the beer market. (Takara Beer is launched.)
1967 Withdrawal from the beer market.
1970 The Central Research Institute is completed in Otsu.
1970 Method for large-scale cultivation of Bunashimeji mushrooms is developed.
1972 Beginning imported sales of Chinese spirts.
1977 Takara Shochu Jun is launched.
1979 Sale of first domestically produced restriction enzymes, research reagents for genetic engineering research, starts.
1983 Takara Sake USA Inc. is established.
1984 Takara Can Chu-Hi is launched.
1988 Exclusive rights to sell gene amplification equipment using the PCR method in Japan are obtained.
1993 Takara Biotechnology (Dalian) Co., Ltd. is established in China.
1993 The exclusive worldwide rights to PCR method are obtained.
1995 The RetroNectin® Method, a highly efficient gene transduction method, is developed.
May 1997 Sale of RetroNectin® reagents used in gene therapy begins worldwide.
Apr. 2000 The long-term management concept Takara Evolution-100 (TE-100) is launched.
Jul. 2000 High-throughout genome sequence center Dragon Genomics Co., Ltd. is established. (Takara Bio acquires Dragon Genomics in October 2002.)
Sep. 2001 Ikkomon (a 100% pure sweet potato shochu) is launched.
Oct. 2001 Shirakabe-gura Brewery is completed at the Nada Plant as the center of Takara’s premium sake business.
Apr. 2002 Holding company Takara Holdings Inc. is established.
Mar. 2003 Production network is revamped. (Takara Shuzo Co., Ltd.)
Dec. 2004 Takara Bio Inc. is listed on the Tokyo Stock Exchange Mothers board.
Sep. 2005 Clontech Laboratories, Inc. is acquired from Becton, Dickinson and Company, of the U.S. (Takara Bio Inc.)
Sep. 2006 The Group’s businesses are reorganized, and Takara Healthcare Inc. is established.
May 2008 The Takara Group's Seventh Medium-Term Management Plan is implemented.
Apr. 2010 Shares in FOODEX S.A.S. are acquired. (Takara Shuzo Co., Ltd.)
Apr. 2011 Long-term management vision Takara Group Vision 2020 is launched.
Takara Group Medium-Term Management Plan FY2014 is launched.
Sep. 2013 The management right in Tazaki Foods Limited is acquired (Takara Shuzo Co., Ltd.)
Apr. 2014 Takara Group Medium-Term Management Plan FY2017 is launched.

Mar. 2016

Takara Bio Inc. changes the listed market in the First Section of the Tokyo Stock Exchange.

Apr. 2017

Takara Group Medium-Term Management Plan FY2020 is launched.

Jul. 2017

Established Takara Shuzo International Co., Ltd.